Trial Profile
A Prospective Randomized Trial to Compare Basal Bolus Therapies That Use Either Insulin Lispro Protamine Suspension [insulin lispro] or Insulin Glargine Together With Lispro Insulin in Patients With Type 2 Diabetes.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin neutral protamine lispro (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 01 Dec 2011 Results published in the Diabetes, Obesity and Metabolism.
- 28 Apr 2010 Actual patient number (75) added as reported by ClinicalTrials.gov.
- 28 Apr 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.